Researchers at Turku University and Åbo Akademi University, Finland, have identified that finger-like cellular extensions called filopodia contribute to building a barrier surrounding breast tumours.
The joint InFLAMES Flagship of the University of Turku and Åbo Akademi University has invited Professor Tero Aittokallio as a Visiting Professor. Aittokallio will give his first InFLAMES Visiting Professor Lecture on Monday October 28th.
The Hospital District of Southwest Finland has chosen the Turku Immunology Centre as its unit of excellence. The Centre, which was established at the end of 2021, was also selected to the Roadmap for Research Infrastructures of the University of Turku.
New discovery on the causes of PAP lung disease can also offer solutions for treating obesity and heart disease. The research group of Associate Professor Alexander Mildner at the University of Turku, Finland, identified a genetic defect that causes the accumulation of lipids in the pulmonary alveoli.
The theme of this year’s BioCity Symposium, immunology, has sparked great interest. Over 400 people have registered for the Symposium that is organised on 25–26 August. The keynote speaker is Sir Peter Ratcliffe, the Nobel Prize Laureate in medicine 2019.
InFLAMES at Europe Forum: Do We Need Science to Boost the Resilience of the Pharmaceutical Industry?
Does Finland need its own drug development and manufacturing or will Europe take care of us even in the event of a crisis? Is the security of medicine supply guaranteed? These and other topics will be discussed in the InFLAMES panel discussion at the science day of the Turku Europe Forum on 24 August. The panel is organised at the Marina Palace at 11.30am-12.15pm. The discussion will be interpreted into English.
Finland's role in the development Europe is at the forefront in the panel discussions organised by the University of Turku and its partners in the Turku Europe Forum. The first day of the Forum on Wednesday, 24 August, focuses on science, and the panellists address numerous questions, such as whether Finland needs its own drug development, what kind of change are Europeans facing in energy production and consumption, where are the borders of Europe, and what is the state of the Archipelago Sea.
Registration to BioCity Symposium is open until 11 August 2022. BioCity Symposium is one of the most important meetings in Turku region for researchers working in the fields of bio- and molecular medicine. This year the event is arranged together with InFLAMES Flagship with title Solution is in Immunity.
– Developing new diagnostic methods for detection and treatment of various diseases are key objectives of the InFLAMES Research Flagship. Collaboration with companies is invaluable to achieve this goal. The next InFLAMES Corporate Corner discusses on how the University and companies are already facilitating the cooperation and what more is needed, both from us and the diagnostics companies, to make the process even smoother” says InFLAMES Project Manager Kaisa Hakkila.
InFLAMES (Innovation Ecosystem based on the Immune System) is a Finnish research flagship that aims at identifying novel drug targets using the most modern technological platforms and finding novel diagnostic tools to identify the patients benefitting from personalised therapies.